Hemab Therapeutics Holdings, Inc. (COAG) SEC filings
COAGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026
$39.06+0.01 (+0.01%)
Close on Nov 17, 2026Market cap $1.82BP/E –Yield –
SEC filings
9 of Hemab Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 10, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2026 | Nov 10, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2026 | Sep 24, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 21, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 21, 2026 | SEC EDGAR |
| Current report | 8-K | May 8, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 4, 2026 | May 4, 2026 | SEC EDGAR |
See a number that looks wrong?